Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk.
Journal: The Journal of infectious diseases
Published: June 23, 2025
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile.
Journal: Antimicrobial agents and chemotherapy
Published: February 16, 2024
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.
Journal: The Journal of infectious diseases
Published: September 07, 2023
Showing 1-3 of 3
Last Updated: 09/26/2026